Core Laboratories Inc reports results for the quarter ended June 30 - Earnings Summary

Core Laboratories

30/07/2026 24:18

Core Laboratories Inc CLB.N reported quarterly adjusted earnings of 11 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 19 cents.  The mean expectation of three analysts for the quarter was for earnings of 9 cents per share. Wall Street expected results to range from 8 cents to 10 cents per share.
Revenue fell 4.3% to $124.61 million from a year ago; analysts expected $125.10 million. 
Core Laboratories Inc's reported EPS for the quarter was 13 cents​.
The company reported quarterly net income of $5.96 million.
Core Laboratories Inc shares had fallen by 8.2% this quarter and lost 33.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 37.4% in the last three months.​ 
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the business support services peer group is  "buy."
Wall Street's median 12-month price target for Core Laboratories Inc is $13.50, about 26.9% above its last closing price of $9.87
This summary was machine generated from LSEG data July 29 at 11:18 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.09
0.11
Beat
Mar. 31 2026 
0.11
0.06
Missed
Dec. 31 2025 
0.19
0.21
Beat
Sep. 30 2025 
0.19
0.22
Beat